We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
Cap. Flow
+$73M
Cap. Flow %
1.04%
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$182M
2
ENDP
Endo International plc
ENDP
+$170M
3
AET
Aetna Inc
AET
+$131M
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$108M
5
BKD icon
Brookdale Senior Living
BKD
+$91.4M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$435M
2
ELV icon
Elevance Health
ELV
+$121M
3
CI icon
Cigna
CI
+$119M
4
WMGI
Wright Medical Group Inc
WMGI
+$82.7M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.8M

Sector Composition

Rank Sector Weight
1 Healthcare 49.34%
2 Financials 7.86%
3 Consumer Discretionary 7.17%
4 Technology 6.32%
5 Industrials 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRA icon
26
Atara Biotherapeutics
ATRA
$75.5M
$47.7M 0.68%
36,181
-219
-0.6% -$251K
SKX
27
DELISTED
Skechers
SKX
$44.6M 0.63%
1,219,278
-684,303
-36% -$22M
ZTS icon
28
Zoetis
ZTS
$32.4B
$44.4M 0.63%
920,313
+497,423
+118% +$23.7M
XL
29
DELISTED
XL Group Ltd.
XL
$43.6M 0.62%
1,173,261
-44,273
-4% -$1.66M
MED icon
30
Medifast
MED
$109M
$43.6M 0.62%
1,350,000
– –
PCRX icon
31
Pacira BioSciences
PCRX
$1.04B
$43.5M 0.62%
+614,800
New +$48.4M
KND
32
DELISTED
Kindred Healthcare
KND
$39.5M 0.56%
1,945,840
+131,498
+7% +$3.01M
SIEN
33
DELISTED
Sientra, Inc.
SIEN
$37.2M 0.53%
147,500
– –
DTV
34
DELISTED
DIRECTV COM STK (DE)
DTV
$37M 0.52%
398,215
-65,404
-14% -$5.91M
KYNB
35
Kyntra Bio
KYNB
$27.2M
$36.9M 0.52%
62,806
+29,870
+91% +$17.4M
ACAD icon
36
Acadia Pharmaceuticals
ACAD
$4.43B
$35M 0.5%
+836,322
New +$32.4M
YHOO
37
DELISTED
Yahoo Inc
YHOO
$34.2M 0.49%
871,558
-328,299
-27% -$14.1M
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$33.6M 0.48%
1,051,479
+75,060
+8% +$1.9M
BHI
39
DELISTED
Baker Hughes
BHI
$30.8M 0.44%
499,657
-106,739
-18% -$6.98M
SIAL
40
DELISTED
SIGMA - ALDRICH CORP
SIAL
$30.5M 0.43%
218,734
+20,423
+10% +$2.84M
ASH icon
41
Ashland
ASH
$3.33B
$29.9M 0.42%
500,690
+283,304
+130% +$17.7M
EXC icon
42
Exelon
EXC
$47.2B
$29.1M 0.41%
1,300,610
+213,359
+20% +$5.11M
ASMB icon
43
Assembly Biosciences
ASMB
$498M
$28.9M 0.41%
125,000
– –
CB icon
44
Chubb
CB
$135B
$27.3M 0.39%
268,956
+90,097
+50% +$9.7M
ALR
45
DELISTED
Alere Inc
ALR
$27.2M 0.39%
514,814
+209,814
+69% +$10.6M
VC icon
46
Visteon
VC
$2.79B
$26.8M 0.38%
255,176
+148,221
+139% +$15.6M
NEE icon
47
NextEra Energy
NEE
$181B
$26.4M 0.37%
1,079,128
-32,148
-3% -$817K
FWONA icon
48
Liberty Media Series A
FWONA
$22.5B
$26.4M 0.37%
1,089,603
-144,278
-12% -$3.72M
PPL
49
PPL Corp
PPL
$26.5B
$25.3M 0.36%
856,816
+843,717
+6,441% +$26.4M
BPMC
50
DELISTED
Blueprint Medicines
BPMC
$25M 0.35%
+945,000
New +$27M
1
2
3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q2 2015 Portfolio in Review

As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
  • Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
  • Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
  • Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
  • Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
  • Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
  • Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.

Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.